Improvement with Fractional Ablative Laser and Topical Poly-L-Lactic Acid in an RDEB Patient

Main Article Content

Samantha L Schneider
Marla Jahnke
Kristin M Leiferman
Marsha Chaffins
Andrew C Krakowski
David Ozog


laser, RDEB, neocollagenesis, scarring


Recessive dystrophic epidermolysis bullosa (RDEB) results from mutations in the COL7A1 gene for type VII collagen. Affected patients demonstrate skin fragility and blistering with scarring. Associated morbidity is great, and there are limited therapeutic options. Fractional carbon dioxide (CO2) ablative laser (FABL) treatments have been shown to promote collagen remodeling and demonstrate synergy with topical poly-l-lactic acid (PLLA) applications. We report the case of a young woman with RDEB who experienced decreased blistering, decreased healing time, and improved quality of life in a local skin area treated with FABL followed by topical PLLA. In comparing biopsy specimens from treated and untreated skin, improved collagen organization and collagen maturity were observed by histopathological examination including with Herovici staining. Moreover, type VII collagen, absent in untreated skin, was detected in treated affected skin by immunostaining. This report illustrates a treatment response to FABL and topical PLLA in a patient with RDEB including enhanced healing time, collagen remodeling, and type VII collagen expression. The findings are promising and, with further study, may have broader implications for treating this disorder.


1. Ibrahim SM, Elsaie ML, Kamel MI, Mohammed EE. Successful treatment of traumatic scars with combined nonablative fractional laser and pinpoint technique of standard CO2 laser. Dermatol Ther. 2016;29(1):52-57.

2. Lee SJ, Suh DH, Lee JM, Song KY, Ryu HJ. Dermal Remodeling of Burn Scar by Fractional CO2 Laser. Aesthetic Plast Surg. 2016;40(5):761-768.

3. Ozog DM, Liu A, Chaffins ML, et al. Evaluation of clinical results, histological architecture, and collagen expression following treatment of mature burn scars with a fractional carbon dioxide laser. JAMA Dermatol. 2013;149(1):50-57.

4. Tierney E, Mahmoud BH, Srivastava D, Ozog D, Kouba DJ. Treatment of surgical scars with nonablative fractional laser versus pulsed dye laser: a randomized controlled trial. Dermatol Surg. 2009;35(8):1172-1180.

5. Krakowski AC, Ghasri P. Case report: rapidly healing epidermolysis bullosa wound after ablative fractional resurfacing. Pediatrics. 2015;135(1):e207-210.

6. Rkein A, Ozog D, Waibel JS. Treatment of atrophic scars with fractionated CO2 laser facilitating delivery of topically applied poly-L-lactic acid. Dermatol Surg. 2014;40(6):624-631.

7. Hasegawa T, Ikeda S. Surgical management with CO2 laser for pseudosyndactyly in recessive dystrophic epidermolysis bullosa. J Dermatol. 2014;41(8):767-768.

8. Minicucci EM, Barraviera SR, Miot H, Almeida-Lopes L. Low-level laser therapy for the treatment of epidermolysis bullosa: a case report. J Cosmet Laser Ther. 2010;12(4):203-205.

9. Krakowski AC, Ozog DM, Ginsberg D, Cheng C, Chaffins ML. Laser-Induced Neocollagenesis in Focal Dermal Hypoplasia Associated With Goltz Syndrome in a Girl. JAMA Dermatol. 2017;153(12):1292-1297.